Literature DB >> 9583685

Evaluation of an autoregulatory tetracycline regulated system.

G L Gallia1, K Khalili.   

Abstract

Tetracycline controlled gene expression systems have become powerful tools in the analysis of gene function in mammalian cell culture as well as transgenic animals and plants. The original description of a tetracycline-regulated gene expression system is based on two plasmids, one of which constitutively expresses a tetracycline-controlled transactivator protein (tTA), a fusion protein between the tetracycline repressor of E. coli and the transcriptional activation domain of the VP16 protein of herpes simplex virus. The second plasmid contains the gene to be regulated by tTA under the control of an inducible promoter which consists of seven copies of the tetracycline resistance operator (tetO). Since this original description, many modifications have been described. In this report, we evaluate an autoregulatory tetracycline controlled system, in which the tTA is itself under the control of the tetO. We demonstrate that this autoregulatory tetracycline system produces adverse effects including cellular morphologic changes, growth rate attenuation and alterations in cell cycle distribution.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9583685     DOI: 10.1038/sj.onc.1201706

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

Review 1.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

Review 2.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

Review 3.  Tumor reversion: correction of malignant behavior by microenvironmental cues.

Authors:  Paraic A Kenny; Mina J Bissell
Journal:  Int J Cancer       Date:  2003-12-10       Impact factor: 7.396

4.  Doxycycline regulation in a single retroviral vector by an autoregulatory loop facilitates controlled gene expression in liver cells.

Authors:  Florian Kühnel; Corinna Fritsch; Sabine Krause; Bettina Mundt; Thomas Wirth; Yasmin Paul; Nisar Peter Malek; Lars Zender; Michael Peter Manns; Stefan Kubicka
Journal:  Nucleic Acids Res       Date:  2004-02-13       Impact factor: 16.971

5.  Visualizing the distribution of synapses from individual neurons in the mouse brain.

Authors:  Ling Li; Bosiljka Tasic; Kristina D Micheva; Vsevolod M Ivanov; Maria L Spletter; Stephen J Smith; Liqun Luo
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

6.  Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter.

Authors:  David Markusic; Ronald Oude-Elferink; Atze T Das; Ben Berkhout; Jurgen Seppen
Journal:  Nucleic Acids Res       Date:  2005-04-04       Impact factor: 16.971

7.  Gateway vectors for efficient artificial gene assembly in vitro and expression in yeast Saccharomyces cerevisiae.

Authors:  Claudiu V Giuraniuc; Murray MacPherson; Yasushi Saka
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

8.  Tetracycline regulated systems in functional oncogenomics.

Authors:  Arkadiusz Welman; Jane Barraclough; Caroline Dive
Journal:  Transl Oncogenomics       Date:  2007-03-28

9.  Stringent and reproducible tetracycline-regulated transgene expression by site-specific insertion at chromosomal loci with pre-characterised induction characteristics.

Authors:  Rachel Brough; Antigoni M Papanastasiou; Andrew C G Porter
Journal:  BMC Mol Biol       Date:  2007-05-10       Impact factor: 2.946

10.  Retroviral vectors for establishing tetracycline-regulated gene expression in an otherwise recalcitrant cell line.

Authors:  Paraic A Kenny; Tariq Enver; Alan Ashworth
Journal:  BMC Mol Biol       Date:  2002-09-03       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.